NCT05330442

Brief Summary

Posttraumatic stress disorder (PTSD) is a significant problem among underserved populations who receive care in community health centers. Several evidence-based psychotherapies for PTSD are not practical given the time and resources required for these approaches. This research will examine whether Written Exposure Therapy (WET), a brief and well-tolerated therapy approach, delivered within collaborative primary care is effective and can be implemented successfully within a collaborative care (CC) intervention. The primary aims of the proposed study are to evaluate the effectiveness and implementation of delivering WET into CoCM to improve the management of PTSD among underserved primary care patients in Federally Qualified Health Centers (FQHCs).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
720

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

10 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Apr 2022Jun 2026

First Submitted

Initial submission to the registry

April 1, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 15, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

April 25, 2022

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

4.1 years

First QC Date

April 1, 2022

Last Update Submit

August 8, 2025

Conditions

Keywords

PTSDbrief psychotherapycollaborative careFederally Qualified Health Centers (FQHCs)primary care

Outcome Measures

Primary Outcomes (3)

  • PTSD Checklist, version 5 (PCL-5)

    PTSD symptoms (total score) and provisional diagnosis anchored to the worst traumatic event

    baseline

  • PTSD Checklist, version 5 (PCL-5)

    PTSD symptoms (total score) and provisional diagnosis anchored to the worst traumatic event

    3-months

  • PTSD Checklist, version 5 (PCL-5)

    PTSD symptoms (total score) and provisional diagnosis anchored to the worst traumatic event

    12-months

Secondary Outcomes (6)

  • Patient Health Questionnaire, 8 items (PHQ-8)

    baseline

  • Patient Health Questionnaire, 8 items (PHQ-8)

    3-months

  • Patient Health Questionnaire, 8 items (PHQ-8)

    12-months

  • Veterans RAND 12-item Health Survey (VR-12)

    baseline

  • Veterans RAND 12-item Health Survey (VR-12)

    3-months

  • +1 more secondary outcomes

Study Arms (2)

CoCM alone

NO INTERVENTION

In the CoCM alone arm, participants will have access to treatment as usual from the CM.

CoCM+WET

EXPERIMENTAL

In the CoCM+WET intervention arm, patients will be encouraged to receive WET.

Behavioral: Written Exposure Therapy (WET)

Interventions

The WET protocol for primary care settings consists of six, 30-minute sessions. The first session consists of psychoeducation of PTSD and treatment rationale. Written narratives are conducted in sessions 2-6, following specific writing instructions and 20 minutes of writing in each session.

CoCM+WET

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients will be included if they are 18 years of age or older, speak English or Spanish, have a scheduled or walk-in appointment with a participating primary care provider (PCP), have no obvious physical or cognitive impairment that would make them unable to complete the assessment (as indicated by confusion or inability to understand the questions), and consider the FQHC to be their usual source of care.

You may not qualify if:

  • Patients will be excluded if they have active psychosis (as indicated by inability to concentrate, having delusions or hallucinations) or high suicide risk (as indicated by having a current plan or means).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Oak Orchard Health Center (Albion)

Albion, New York, 14411, United States

Location

Brownsville Health Center (Genesis and Ashford - BGA)

Brooklyn, New York, 11212, United States

Location

Brownsville Health Center (Main)

Brooklyn, New York, 11212, United States

Location

Bedford Stuyvesant Family Health Center (Main)

Brooklyn, New York, 11216, United States

Location

Bedford Stuyvesant Family Health Center (Sterling and Broadway)

Brooklyn, New York, 11216, United States

Location

Oak Orchard Health (Pembroke)

Corfu, New York, 14036, United States

Location

Open Door Family Medical Center (Brewster/Ossining)

Ossining, New York, 10562, United States

Location

Open Door Family Medical Center (Mamaroneck//Port Chester)

Port Chester, New York, 10573, United States

Location

OIC Family Medical Center (Fairview)

Rocky Mount, North Carolina, 27801, United States

Location

OIC Family Medical Center (Happy Hill)

Rocky Mount, North Carolina, 27804, United States

Location

Related Publications (1)

  • Meredith LS, Wong EC, Marx BP, Han B, Korn AR, Tobin JN, Cassells A, Williamson S, Franco M, Overa CC, Holder T, Lin TJ, Sloan DM. Design of a hybrid implementation effectiveness cluster randomized controlled trial of delivering written exposure therapy for PTSD in underserved primary care settings. Contemp Clin Trials. 2024 Mar;138:107435. doi: 10.1016/j.cct.2024.107435. Epub 2024 Jan 9.

    PMID: 38211725BACKGROUND

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Jessica Higby

    RAND

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes assessors will not know which are patients within health centers are assigned to because they will be independent of the participant recruitment coordinators.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Matched pairs of health centers/FQHCs will be randomized to either CoCM alone or to CoCM+WET.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2022

First Posted

April 15, 2022

Study Start

April 25, 2022

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

At the end of the study, the research programmer will upload participant data to the NIMH Data Archive.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
May 2026
Access Criteria
Data will be shared through the NIMH Data Archive

Locations